 MALVERN, Pa., Feb. 18, 2022 GLOBE NEWSWIRE -- Ocugen, Inc. NASDAQ: OCGN, a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19, today announced that it will host a conference call to discuss its fourth quarter and full year 2021 financial results and provide a business update at 8:30 a.m. ET on Friday, February 25, 2022. 